McKinley Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,760
Closed -$2.33M 144
2024
Q1
$2.33M Hold
26,760
0.28% 95
2023
Q4
$2.2M Hold
26,760
0.28% 94
2023
Q3
$2.1M Hold
26,760
0.29% 97
2023
Q2
$2.36M Sell
26,760
-3,500
-12% -$301K 0.32% 92
2023
Q1
$2.44M Hold
30,260
0.32% 90
2022
Q4
$2.35M Sell
30,260
-36,280
-55% -$2.94M 0.32% 94
2022
Q3
$5.37M Hold
66,540
0.73% 39
2022
Q2
$5.97M Hold
66,540
0.78% 37
2022
Q1
$7.38M Hold
66,540
0.74% 41
2021
Q4
$6.88M Sell
66,540
-39,910
-37% -$4.62M 0.62% 53
2021
Q3
$13.3M Hold
106,450
1.26% 16
2021
Q2
$13.2M Hold
106,450
0.92% 31
2021
Q1
$12.6M Hold
106,450
0.95% 33
2020
Q4
$12.5M Hold
106,450
0.89% 36
2020
Q3
$11.1M Hold
106,450
0.86% 38
2020
Q2
$9.76M Hold
106,450
0.67% 48
2020
Q1
$9.6M Hold
106,450
0.77% 48
2019
Q4
$12.1M Buy
+106,450
New +$11.7M 0.79% 48
2019
Q3
Sell
-16,280
Closed -$1.59M 199
2019
Q2
$1.59M Buy
+16,280
New +$1.49M 0.1% 124
2016
Q4
Sell
-1,970
Closed -$170K 543
2016
Q3
$170K Buy
1,970
+1,590
+418% +$139K 0.01% 368
2016
Q2
$33K Buy
+380
New +$30.7K ﹤0.01% 343

Other funds holding MDT

McKinley Capital Management's MDT Position: Q2 2024 in Review

McKinley Capital Management sold out of Medtronic (MDT) in Q2 2024, closing a stake of 26,760 shares — an estimated $2.33M sold.

McKinley Capital Management first reported a position in MDT in Q2 2016 and held it in 21 quarters. The position peaked at $13.3M in Q3 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • McKinley Capital Management reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • McKinley Capital Management sold 26,760 Medtronic shares in Q2 2024, an estimated $2.33M.
  • McKinley Capital Management first reported a position in Medtronic in Q2 2016 and held it in 21 quarters.
  • McKinley Capital Management's Medtronic position peaked at $13.3M in Q3 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.